Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)

Donna Vizi

Commercial Road, 
Melbourne, VIC, AU 
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Commercial Road, 
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Donna Vizi practices in Melbourne, Australia. Ms. Vizi is rated as a Distinguished expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Atrial Fibrillation, Serotonin Syndrome, and Cardiac Ablation.

Her clinical research consists of co-authoring 21 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 11 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Female

Locations

Commercial Road, Melbourne, VIC 3004, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Interactions Between The Serotonin Transporter And Sympathetic Nervous System Activation In Patients With Major Depressive Disorder - Understanding The Link Between The Brain And The Heart
Interactions Between The Serotonin Transporter And Sympathetic Nervous System Activation In Patients With Major Depressive Disorder - Understanding The Link Between The Brain And The Heart
Enrollment Status: Completed
Publish Date: September 14, 2023
Intervention Type: Drug
Study Drug: Selective Serotonin Re-Uptake Inhibitor (SSRI) Antidepressant
Study Phase: Phase 4
A Randomised Trial Examining the Effectiveness of Sympathetic Nervous Inhibition in Alleviating the Metabolic Side Effects of Antipsychotic Medications in Patients With Schizophrenia
A Randomised Trial Examining the Effectiveness of Sympathetic Nervous Inhibition in Alleviating the Metabolic Side Effects of Antipsychotic Medications in Patients With Schizophrenia
Enrollment Status: Withdrawn
Publish Date: April 24, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

21 Total Publications

Insights into pulmonary remodelling in heart failure with preserved ejection fraction through transpulmonary biomarker gradients.
Insights into pulmonary remodelling in heart failure with preserved ejection fraction through transpulmonary biomarker gradients.
Journal: Cardiovascular research
Published: March 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Vizi's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile